Medpacto acquires a patent for cancer diagnosis using blood

Medpacto acquires a patent for cancer diagnosis using blood Dominating the market and securing rights for the core technology of the cancer diagnostic kit 'MO-B2' Clinical trial expected after testing of prototypes in the second half of this year [Mar 16, 2021] Medpacto (CEO Seong-jin Kim) announced on the 16th that it has registered a domestic patent on a method for diagnosing cancer with blood. This patent relates to a method for diagnosing cancer by measuring the expression rate of BAG2 protein present in blood. Medpacto secures exclusive rights for the development of BAG2-based d..........

원문링크 : Medpacto acquires a patent for cancer diagnosis using blood